Pakistan continues to be dealing with a polio outbreak as four fresh cases have emerged, pushing the national tally to 37 this year, according to health officials on October 19, 2024. Health officials said that the regional reference laboratory for polio eradication at the National Institute of Health in Islamabad confirmed wild poliovirus type-1 (WPV1) in two children-one from each Balochistan and Khyber-Pakhtunkhwa.

In recent cases, a girl has been affected from Pishin, and two boys from Chaman and Noshki of Balochistan, and a girl from Lakki Marwat in KP. These are the first detections of the virus within Noshki and Lakki Marwat this year; isolated cases of poliovirus were previously reported within Chaman and Pishin. The province of Balochistan was the worst hit with 20 cases, Sindh had 10, Khyber Pakhtunkhwa had five, and Punjab and Islamabad had one case each.

A gigantic fight against polio has been on going in Pakistan- especially in Balochistan and southern KP-over the last two years. Immunisation campaigns have often been suspended or delayed because of local protests, insecurity, and community boycotts. Consequently, quite a number of children did not get the necessary vaccinations, making existing patches of vulnerability for the virus to flow within those pockets.

Noshki, located near Afghanistan's border, and Lakki Marwat have also recently reported some positive environmental samples that confirm the virus is present here, said a local reference laboratory official. Samples of latest cases are currently under genetic sequencing for checking spread of virus and origin.

As the threat of polio continues to grow, Pakistan has vowed to mount a nationwide campaign against it beginning from October 28. With the zeal to tackle the menace in the most effective manner, over 45 million children under the age of five will be vaccinated across the country.

Today, Afghanistan and Pakistan remain one of the few countries where polio has not yet been eradicated. The WHO said the virus remains a potential serious public health threat in areas with low vaccination coverage and weak surveillance.

India On Alert Against Polio

The country declared itself polio-free since 2014 and has kept the disease on bay almost a decade with very robust vaccination programs; however, two cases of vaccine-derived poliovirus cases reported in recent days from Meghalaya create some amount of doubts over a possible resurgence. Experts observe that in India, despite these detections taking place, strong coverage of vaccination at 90-95% and mandatory surveillance measures keep the risk of this widespread outbreak at bay.

The experts point out, however, that such stable situation in India requires continued surveillance. "Countries like Pakistan and parts of Africa remain at a high risk because vaccination rates in those areas are much lower," Dr. Siddharth, public health expert, said. Vaccination is an indispensable act in order to avoid the spread of this incapacitating disease that manifests most importantly as a nervous system affliction leading to the paralysis of a long period.

With concerted efforts from health authorities, there is hope someday that the scourge of polio will be completely eradicated from the face of the earth and future generations will never suffer from its effects.

The US Centers for Disease Control and Prevention (CDC) has reported its ninth gastrointestinal (GI) illness outbreak linked to a cruise ship in 2026 after 13 people fell ill aboard the National Geographic Sea Bird.

The CDC is investigating the incident, and the cause of the outbreak has not yet been identified. The affected vessel is operated by Lindblad Expeditions.

The latest incident is also the ship's fourth gastrointestinal illness outbreak in less than two months, following one outbreak each in May and June and a second outbreak in July.

“Eight of the 57 guests sailing aboard National Geographic Sea Bird reported being ill during its July 15 voyage, along with five crew members,” the CDC said in a statement. Their predominant symptoms include diarrhea, vomiting, and abdominal cramps.

In response, Lindblad Expeditions said it has intensified cleaning and disinfection measures and isolated affected passengers and crew members to help limit the spread of illness.

The company has also canceled three scheduled passenger voyages departing on July 20, July 25, and July 30 to carry out enhanced sanitation procedures.

The cruise operator said the pause will allow it "to conduct enhanced sanitation protocols aligned with the highest industry standards and provide additional time to help prevent the risk of further cases."

"We are working directly with affected guests to provide refunds, support and alternative travel arrangements," Lindblad told USA TODAY in an emailed statement.

What Are Gastrointestinal Illnesses?

Gastrointestinal illnesses, also known as gastroenteritis, are the inflammation of the stomach and intestines that causes vomiting, diarrhea, cramps in the abdomen, and occasionally fever or muscle pain.

Commonly called the "stomach flu," it is not caused by the flu virus and has nothing to do with respiratory infections. Rather, it is usually caused by infection or chemical irritants to the gastrointestinal (GI) tract. There are two main types:

1. Infectious gastroenteritis – due to viruses, bacteria, parasites, or fungi.
2. Chemical gastroenteritis – due to ingestion of poisonous substances such as some drugs, alcohol, or polluted food/water.

How Does Gastroenteritis Spread?

The most prevalent reason for gastroenteritis is the intake of contaminated food or water. It is also spread by contact with infected people or surfaces they have contacted. Some typical situations include:

• Consumption of undercooked meat or seafood
• Inadequate washing of hands after using the toilet
• Drinking unbottled or unfiltered water during travel

Though most individuals recover quickly, individuals with compromised immune systems—such as young children, the elderly, or those with chronic diseases—are at a higher risk for developing complications like dehydration and extended illness.

Symptoms Of Gastroenteritis

Acute gastroenteritis usually presents with a combination of the following:

• Sudden onset of watery diarrhea (non-bloody)
• Nausea and vomiting
• Abdominal cramps or bloating
• Low-grade fever
• General fatigue or muscle aches

These symptoms typically occur within 1–3 days of contact with the infection and can last anywhere from 24 hours up to two weeks, depending upon the cause and the immune response of the patient.

Extreme age groups, especially very young infants and the elderly, are at higher risk due to dehydration from diarrheal illness. However, deaths remain rare when proper care is provided.

What You Can Do To Stop Its Spread

Because of how fast viruses spread, experts highly recommend preventive actions such as:

• Wash your hands frequently with soap and warm water, especially after using the toilet or before preparing food.
• Avoid visiting hospitals or care homes if experiencing symptoms.
• Stay home for at least 48 hours after symptoms subside to prevent spreading the virus.

Johnson & Johnson is about to end what can be described as one of the most controversial lawsuits in the pharmaceutical industry. The pharma giant has agreed to pay $5.5 billion to settle tens of thousands of cases alleging that its baby powder and other talc products can cause ovarian cancer.

The settlement covers around 76,000 lawsuits pending across U.S. federal and state courts. It will be final after it gets approved by 95% of eligible claimants. If finalized, a few payments are expected to begin in 2027, with additional payouts extending into 2028.

Johnson & Johnson To Settle Talc-Cancer Lawsuit

According to Reuters, the settlement covers 99.75% of the remaining ovarian cancer claims against Johnson & Johnson.

The company has previously resolved most lawsuits involving mesothelioma, another cancer linked to alleged asbestos in its talc products.

The agreement comes after years of courtroom battles, manipulative bankruptcy strategies, and mixed trial verdicts.

It also follows a recent ruling by a U.S. federal judge questioning whether plaintiffs' expert witnesses had provided the court with sufficient scientific evidence that links talc use directly to ovarian cancer, a development that strengthened J&J's legal position ahead of negotiations.

Also read: US Man Says ChatGPT's Medical Advice Nearly Killed Him: How Safe Is AI for Health Questions?

Johnson & Johnson Continues To Plead 'Not Guilty'

Despite agreeing to the massive settlement, Johnson & Johnson continues to deny that its talc products caused cancer.

Erik Haas, the pharma company's Vice President of Litigation, said the claims were "meritless" and that the company chose to settle to obtain closure after years of litigation.

The company has consistently maintained that its talc products are safe, asbestos-free, and that the settlement does not constitute admission of any wrongdoing.

The law firms representing thousands of women reportedly welcomed the agreement, describing it as a long-awaited resolution after nearly a decade of tedious litigation.

According to Reuters, attorneys representing the claimants said the settlement delivers meaningful compensation to affected women and their families after years of legal ambiguity.

Also read: Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Ads: Should GLP-1 Users Be Concerned?

J&J Talc-Cancer Lawsuit: About The Controversial Case

The lawsuits became one of the largest mass tort cases. The case combined complex scientific questions with allegations that the company knew of possible health risks but failed to warn the consumers and continued to sell the products.

The case dates back more than a decade, when women who had regularly used Johnson's Baby Powder for feminine hygiene began filing lawsuits alleging that it had increased their risk of ovarian cancer.

Another group of lawsuits alleged that certain talc products contained asbestos, a known carcinogen that could cause mesothelioma.

Johnson & Johnson has repeatedly denied that its talc products contain asbestos or caused cancer.

The first major jury verdict awarded $72 million to the family of Jacqueline Fox, who died from ovarian cancer after decades of talc use. Although the verdict was later overturned, it sparked thousands of similar lawsuits.

A California jury awarded $417 million to Eva Echeverria, who claimed long-term use of Baby Powder caused her ovarian cancer.

One of the largest verdicts came when 22 women were awarded $4.69 billion (later reduced on appeal to $2.1 billion) after a Missouri jury found J&J liable for failing to warn consumers about asbestos in their talc products.

Some studies found a link between genital talc use and ovarian cancer, whereas others found insufficient evidence. This disagreement remains the highlight of the courtroom battles even today with no definite discovery.

The US Food and Drug Administration (FDA) has approved SimpleScreen CRC, a new blood-based screening test for colorectal cancer (CRC), the second-leading cause of cancer-related death in America.

Developed by Freenome, the test is intended for adults aged 45 and older who are at average risk for CRC. It detects cancer-associated signals from cell-free DNA (cfDNA) in the blood. However, the company said it is not a replacement for diagnostic or surveillance colonoscopy in high-risk individuals.

"A blood-based test provides another way to reach unscreened patients, and bringing more people into the screening fold leads to earlier detection and better outcomes," said Aasma Shaukat, Professor of Medicine at NYU Grossman School of Medicine.

How Does the SimpleScreen CRC Test Work?

The test is indicated for adults aged 45 years and older who are at average risk for CRC and have been referred by a healthcare provider for screening. A positive result suggests the possible presence of colorectal cancer or advanced precancerous lesions and should be followed by a colonoscopy.

A study, which enrolled over 48,000 adults across more than 200 sites, demonstrated that the test has:

• 81.1% sensitivity for detecting colorectal cancer.
• 13.7% sensitivity for detecting advanced precancerous lesions (APLs), including 30.7% for APLs with high-grade dysplasia.
• 90.4% specificity for advanced colorectal neoplasia.

Abbott will exclusively commercialize SimpleScreen CRC in the US.

Also read: India's National Hepatitis Program Screens Over 210.6 Million, Treats 612,000 Patients

Why Is Colorectal Cancer Screening Important?

Colorectal cancer is highly preventable and treatable when detected early through screening. Up to 60 million Americans remain overdue for recommended screening, highlighting the need for more convenient screening options.

Although up to 90% of colorectal cancer deaths are preventable, the disease is still expected to claim more than 55,000 lives in the US this year. Regular screening remains key to early detection and improved outcomes.

What Is Colorectal Cancer?

Read More: Europe Swelters Under Heatwave And Wildfires; 360,000+ Evacuated: What Are The Health Risks?

Also called colon cancer, colorectal cancer is among the most common cancers globally, yet it often goes unnoticed because its symptoms can be subtle.

"It's a cancer that can creep in quietly, and by the time it's diagnosed, it may already be at an advanced stage," said Dr. Sajjan Rajpurohit, Medical Oncologist at BLK-Max Super Speciality Hospital. "Early detection is the most powerful tool in improving survival rates."

Early Symptoms People Ignore

Colon cancer often develops with subtle symptoms that are easy to overlook.

Common early signs include:

• Persistent changes in bowel movements, such as chronic constipation or diarrhea.
• Blood in the stool, whether bright red or dark.
• Unexplained weight loss.
• Abdominal cramps or bloating that may be mistaken for common digestive issues.